Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Orange III: Movicol Preoperative Use in Enhanced Recovery After Liver Resection
2011-003129-92Phase 4Active
- Sponsor
- Maastricht University Medical Center+
- Start
- Mar 2012
- Modality
- Biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Non-biodegradable Polymers → Polymer-based Nanoparticles → Nanoparticles → Drug Delivery Systems, Injectable Hydrogels → Hydrogel Systems → Drug Delivery Systems
- Countries
- 1
01
Overview
A Phase 4 trial of polyethylene glycol in hepatic disease, perioperative gastrointestinal dysfunction (POGD), sponsored by Maastricht University Medical Center+. Started Mar 2012; status: active.
02
Drugs
polyethylene glycol
03
Conditions
hepatic diseaseperioperative gastrointestinal dysfunction (POGD)
Beyond the preview
Go deeper on 2011-003129-92.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2011-003129-92.